The Drosophila Yorkie (Yki) protein and its mammalian homolog Yes-associated protein (YAP) are potent growth promoters, and YAP overexpression is associated with multiple types of cancer [1, 2] . Yki and YAP are transcriptional coactivators and function as downstream effectors of the Hippo tumor suppressor pathway [1] [2] [3] [4] . The regulation of Yki and YAP by the Hippo signaling pathway has been extensively investigated; however, how they regulate gene expression is poorly understood. To identify additional regulators of Yki activity, we performed a genome-wide RNAi screen in Drosophila S2 cells. In this screen, we identified the conserved protein Mask (Multiple ankyrin repeats single KH domain) as a novel promoter of Yki activity in vitro and validated this function in vivo in Drosophila. We found that Mask is required downstream of the Hippo pathway for Yki to induce target-gene expression and that Mask forms complexes with Yki. The human Mask homolog MASK1 complexes with YAP and is required for the full activity of YAP. Additionally, elevated MASK1 expression is associated with worsened outcomes for breast cancer patients. We conclude that Mask is a novel cofactor for Yki/YAP required for optimal Yki/YAP activity during development and oncogenesis.
Results and Discussion

Mask Is a Positive Regulator of Yki Activity In Vitro
To identify new components of the Hippo pathway and potential regulators of Yorkie (Yki) activity, we performed a genomewide RNAi screen in S2 cells, using a Yki-dependent luciferase assay [5, 6] . In this assay, a fusion protein between Yki and the GAL4 DNA-binding domain (Yki-GDBD) drives expression of a UAS-luciferase construct. Coexpression of Expanded (Ex) was used to activate the Hippo pathway and diminish baseline Yki activity [6] . In a secondary assay, we eliminated false positives that have general effects on transcription by testing for effects on a fusion protein between Scute (Sc) and the GAL4 DNA-binding domain (GDBD). Sc-GDBD is not regulated by Hippo signaling but induces luciferase expression levels comparable to the Yki-GDBD construct [6] . In this screen, we identified the known Hippo pathway components Hpo, Ex, Wts, Kibra, Sav, and Mats, as well as actin regulators [6] , as negative regulators of Yki activity, which validated the screening strategy and supported its utility for identifying novel components of the pathway ( Figure 1A ). In addition to these negative Yki regulators, we identified Multiple ankyrin repeats single KH domain (Mask) as a protein that promotes Yki activity ( Figure 1A) . Knockdown of mask resulted in a 50% reduction of Yki-GDBD-induced luciferase expression, whereas it did not affect Sc-GDBD-induced reporter expression ( Figure 1B ). These results indicate that the reduction in Yki activity caused by mask knockdown is specific and is not the consequence of general effects on transcription. We focused our further studies on Mask because knockdown of mask had some of the strongest effects on Yki-GDBD activity observed in the screen (apart from knockdowns that resulted in cell death) and because Mask also had robust and specific effects on Yki activity in vivo.
Mask Is Required for Normal Tissue Growth and Yki Target-Gene Expression in Drosophila
Mask is a large protein of 4,001 amino acids that contains two clusters of ankyrin repeats (Ank1 and Ank2) and a single KH domain in its C terminus ( Figure 1C ) [7] . Ankyrin repeats are known to mediate protein-protein interactions, and KH domains can mediate protein-nucleic acid interactions [8, 9] . Previous studies identified mutations in mask as modifiers of epidermal growth factor (EGF) signaling and also identified a role for Mask in photoreceptor differentiation, cell survival, and proliferation in Drosophila [7] , although the molecular mechanism of Mask action was not known. Mask is conserved in humans, where there are two homologs, MASK1 (also known as ANKHD1) and MASK2 (also known as GTAR or ANKRD17) ( Figure 1C ) [7, 10] . MASK1 is overexpressed in acute leukemia patient cells and cell lines [11] and regulates cell-cycle progression and proliferation in multiple myeloma [12] . MASK2 is essential for vascular integrity during embryogenesis [13] .
To investigate a potential role for Mask in Hippo signaling in vivo, we first tested whether there is a general requirement for mask in tissue growth. We found that larvae with mosaic eye discs, in which most cells were homozygous mutant for the null allele mask 5.8 [7] , produced flies with small eyes that lacked mutant cells and had only a few heterozygous cells ( Figures 1D and 1E ). Eye discs mosaic for the hypomorphic mask 6.3 allele [7] also produced small eyes but contained homozygous cells, although their amounts were still far below control eyes ( Figures 1D and 1F) . In imaginal discs, mask null clones grew poorly in all areas of developing eye and wing discs and were eventually eliminated during late stages of development, and hypomorphic clones grew at reduced rates (see Figures S1A-S1C available online) [7] . Broad knockdown of mask during eye development by ey-GAL4-driven expression of genome-encoded double-stranded RNAs (ey-GAL4>UAS-mask RNAi ) resulted in adult flies that had severely reduced eyes (Figures S1E-S1G) . Similarly, knockdown of mask expression in the developing wing pouch, using the nub-GAL4 driver, resulted in smaller wings with some wing margin defects ( Figures S1H-S1K) . Notably, four different nonoverlapping mask-RNAi constructs showed similar effects, although with varying strengths ( Figure S1 ), and mask mRNA levels were reduced even by a moderate RNAi line, as measured by qRT-PCR ( Figure S1M ). On the other hand, overexpression of Mask using nub-GAL4 driving different EY insertions in mask did not affect wing size (data not shown). These data indicate that Mask is generally required for normal tissue growth, similar to the requirement for Yki [5] .
Based on our in vitro data and the requirement for Mask in tissue growth, we hypothesized that Mask acts in the Hippo pathway. To test this hypothesis, we examined the expression of Yki target genes in cells with reduced mask expression.
Clones of cells mutant for the null allele mask 5.8 were generally composed of only very few cells and thus difficult to analyze ( Figure S1B ). However, clones mutant for the hypomorphic mask 6.3 allele were larger and showed reduced expression of the expanded-lacZ (ex-Z) reporter, a commonly used and sensitive readout for Yki activity ( Figure 1G ) [14] . Likewise, when mask expression was knocked down in the posterior compartment of developing wing discs by RNAi, ex-lacZ was strongly reduced when compared to control discs and to its expression in the anterior compartment ( Figures 1H and 1I ). In addition, compartment size was reduced ( Figures 1H and  1I ). This result is strikingly similar to the reduced expression of ex-lacZ and small compartment size observed when yki expression was knocked down in the posterior compartment using RNAi ( Figure 1J ) [15] 2B ; data not shown) [16, 17] . Conversely, knockdown of yki or mask resulted in wings that were much smaller than normal ( Figures 2C and 2G ) [15] . Simultaneous knockdown of hpo, ex, or fat together with yki produced the yki knockdown phenotype of small wings, showing that Yki activity is required for the overgrowth caused by Hippo pathway inactivation, as expected ( Figure 2H ). Similarly, when mask was knocked down together with fat, ex, or hpo, wing overgrowth was suppressed and the adult wings were small ( Figure 2D ; data not shown). These results indicate that Mask functions within the Hippo pathway downstream of Fat, Ex, and Hpo. We then tested whether Yki activity itself was dependent upon Mask. To investigate this, we first overexpressed Yki with and without knockdown of mask. Overexpression of wild-type Yki is sufficient to induce wing overgrowth (Figure 2E ) [5] , but, in combination with knockdown of mask, the adult wings exhibited the mask RNAi phenotype ( Figure 2F ), namely small wings with distal scalloping ( Figure 2C ). Thus, overexpressed Yki requires Mask to cause overgrowth. However, wild-type Yki can still be regulated by Wts phosphorylation, and this experiment thus does not discriminate between direct effects on Yki and indirect effects through modulating Wts. We therefore repeated this experiment with mutant versions of Yki, namely Yki1SA and Yki3SA, in which the main or all three Wts phosphorylation sites were mutated to alanine [18] . Overexpression of Yki1SA or Yki3SA by nub-GAL4 caused severe overgrowth phenotypes in discs ( Figures  2I-2L ), which were not able to produce adult wings. Coexpression of mask-RNAi partially rescued these overgrowth phenotypes, indicating that even nonphosphorylatable Yki requires Mask for its growth-inducing activity ( Figures 2M-2P , quantified in Figure 2Q ). To further quantify the effects of Mask on the activity of Yki independent of Wts phosphorylation, we used the Yki-GDBD luc assay in S2 cells. We found that Mask was again required for the full activity of Yki with wtsRNAi and of unphosphorylatable Yki3SA ( Figure 2R ). However, mask knockdown did not completely inactivate wild-type or mutant Yki, even though mask mRNA levels were nearly undetectable in mask RNAi cells ( Figure 2S) . Therefore, Mask is not absolutely required for Yki activity.
This conclusion was further confirmed in S2 cells, where knockdown of mask reduced the activity of a reporter construct containing binding sites for Scalloped (Sd), a transcription factor that interacts with Yki, by about 50% ( Figures  2T and 2U) . This was true when the reporter was driven by endogenous levels of Yki and Sd ( Figure 2T ) or when Yki was overexpressed ( Figure 2U ). We next analyzed the clonal growth and levels of ex-lacZ expression in wts single-mutant and wts, mask double-mutant clones. wts null mutant clones grew large and consistently had high levels of ex-lacZ expression ( Figure 2V ). In contrast, wts, mask double-null mutant clones were generally smaller, and about half of these clones had no or weak upregulation of ex-lacZ expression ( Figure 2W,  arrowhead) , although the other half had elevated levels ( Figure 2W, asterisk) . These in vivo data thus show that Mask is required for the full wts mutant phenotype but that loss of Wts can still enhance the activity of Yki, even in the absence of Mask. Altogether, the in vivo and in vitro experiments show that Mask is required for full activity of Yki and that at least part of this function is independent (in parallel or downstream) of the activity of Wts.
The above data indicate that the activities of Mask and Yki may be closely linked. To determine whether Mask can physically interact with Yki, we coimmunoprecipitated V5-tagged Yki with HA-tagged Mask constructs. We found that the Ank2 and KH domains, as well as a construct that contained the Ank2-KH domains together, formed complexes with Yki, whereas Ank1 complexed weakly ( Figure 3A) . We also tested for interaction with Wts but found that none of the Mask domains bound to Wts ( Figure 3A ). This experiment also demonstrates the specificity of the interaction between Mask and Yki. Together with our in vivo and S2 cell data, we conclude that Mask represents a novel component of the Hippo pathway that positively regulates Yki activity, likely through a direct interaction with Yki.
We then assayed whether Mask and Yki influence each other's subcellular localization. Mask and Yki are localized mainly in the cytoplasm in imaginal disc cells and in S2 cells [5, 7] , and Yki translocates to the nucleus when the Hippo pathway is inactivated [5] . However, we did not observe significant effects on Mask localization in wts mutant clones ( Figures S3A and S3B) . We then tested whether, in S2 cells, nuclear translocation of Yki is sufficient to recruit Mask into the nucleus. For this experiment, we analyzed the localization of tagged Yki and tagged Ank2-KH Mask proteins. We found that coexpression of Sd efficiently recruited Yki into the nucleus, but not Mask ( Figure 3F , quantified in Figures  3G and 3H) . Thus, Mask and Yki do not form obligatory complexes, and the regulation of Mask localization may be independent of the Hippo pathway. Conversely, knockdown of mask caused a slight increase in nuclear localization of Yki in S2 cells, similar to the effect of wts knockdown ( Figure 3I ). Knockdown of mask in imaginal discs did not noticeably affect the localization pattern of Yki, but it resulted in an increase of Yki protein levels ( Figures S3C and S3D) . However, even though mask RNAi cells had elevated levels of Yki protein, they had less Yki activity, further supporting the idea that Mask is required for full activity of Yki. MASK1 copurified YAP, indicating that MASK1 and YAP form complexes (Figure 4A ). In addition, we found that immunoprecipitation of MASK1 also copurified endogenous TEAD3 ( Figure 4A ). Knockdown of MASK1 significantly reduced the amount of coimmunoprecipitated YAP and TEAD3, whereas the total amount of YAP in the cell lysates was not affected, and TEAD3 was slightly lower ( Figure 4A ). We next wanted to determine the cellular localization of these proteins. MASK1 mainly localized to the cytoplasm, and YAP was evenly distributed in nuclei and cytoplasm in our assay conditions (Figures 4B and  4C) . We then used the proximity ligation assay (PLA) to visualize the localization of the heteromers of MASK1 with YAP or TAZ. Such heteromers were readily detected in the cytoplasm but also observed in the nuclei of HEK293T cells treated with nontargeting siRNAs (Figures  4D and 4F ; Figure S4 ). Upon MASK1 knockdown, the number of complexes was significantly reduced (Figures 4E and 4F; Figure S4 ). Together, these data indicate that endogenous MASK1 and YAP form complexes.
To examine whether MASK1 is required for the transcriptional activity of YAP/TEAD complexes, we assayed the ability of MASK1 to modulate the activity of a commonly used TEAD luciferase reporter [19] . We transfected HEK293T cells with si-MASK1, which resulted in a significant reduction of MASK1 expression ( Figure 4G ) and significantly reduced TEAD-dependent luciferase reporter activity when compared with a nontargeting siRNA control (p < 0.005) ( Figure 4H ). We also assayed for YAP/TEAD target-gene expression by qRT-PCR in HEK293T cells transfected with si-MASK1 or nontargeting siRNA. We found that the expression of the YAP target genes CTGF, ANKRD1, FN1, and CYR61 were significantly reduced, whereas nontarget genes, such as KRAS, NRAS, and MYC, as well as YAP and TAZ themselves, were not affected ( Figure 4I ). Together, these data indicate that MASK1 is required for full activity of YAP/TEAD.
Deregulation of the Hippo pathway is frequently detected in human cancers, and increased YAP activity correlates with poor prognosis and patient survival [1, 2] . Additionally, MASK1 is overexpressed in acute leukemias [11] and regulates cell-cycle progression and proliferation in multiple myeloma cells [12] , suggesting that it may have oncogenic activity. To examine whether there is a relationship between clinical prognosis and expression of MASK1 in human cancers, we analyzed gene expression profiles of different breast cancer data sets, using probes that identify the first ankyrin domain of MASK1 mRNA. We found that low expression of MASK1 is associated with significantly better relapse-free survival in two independent data sets (p < 0.007, p < 0.014): University of North Carolina (data sets from [20] [21] [22] hosted by the UNC Microarray Database at https://genome.unc.edu) ( Figure 4J ) and Pawitan et al. [23] (Figure 4K ). These findings suggest that MASK1 levels are an important factor in the aggressiveness of cancer progression and patient outcomes.
In summary, we identified Mask as a novel component of the Hippo pathway. We found that Mask and its mammalian homolog MASK1 form complexes with the Hippo pathway effector Yki/YAP and are required for full activity of Yki/YAP. We also found that MASK1 expression levels correlate with breast cancer patient outcomes. In an accompanying paper in this issue of Current Biology, Sidor et al. [24] similarly report an interaction between Mask and Yki/YAP. The mechanism by which Mask/MASK1 potentiates Yki/YAP activity is currently not known, but our data suggest a model in which Mask/MASK1 acts in the nucleus to promote Yki/YAP's transcriptional coactivator function, although Mask/MASK1 may also function in the cytoplasm to promote Yki/YAP activity. In any case, our data indicate that Mask/MASK1 acts in parallel to the Wts-mediated phosphorylation and regulated localization, and Mask/MASK1 may thus identify a novel regulatory branch of the Hippo pathway.
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